AQP5 and lipoid nephrosis: In the same experiment, using immunofluorescence on human kidney biopsies, it was found that in controls (patients with minimal change disease, MCD), AQP5 was not identifiable, while it was hyper-expressed in patients with diabetic nephropathy.